Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
SAGE Open Med Case Rep ; 10: 2050313X221105829, 2022.
Article in English | MEDLINE | ID: mdl-35769831

ABSTRACT

This report presents a case study on giant left atrial myxoma. Transthoracic echocardiography showed a giant mass in the left atrium of a 53-year-old female patient causing functional mitral stenosis. Tumor resection was performed, and the pathological diagnosis confirmed the atrial myxoma. Postoperative echocardiography showed no evidence of any remaining mass and mitral stenosis.

2.
Ann Vasc Dis ; 15(4): 282-288, 2022 Dec 25.
Article in English | MEDLINE | ID: mdl-36644258

ABSTRACT

Objective: Arteriovenous graft (AVG) infection influences the survival and quality of life of patients, causing life-threatening sepsis reducing dialysis access. This study aimed to evaluate an appropriate treatment strategy for AVG infection. Methods: We analyzed 61 cases involving AVG infections identified at a single center. The cases were divided into two groups based on the type of AVG and surgical methods, namely, currently used AVG (cAVG) (n=29) or abandoned AVG (aAVG) (n=32) and total graft excision (TGE) (n=10) or partial graft excision (PGE) (n=46). Results: There was a significant difference in lower procedure frequency (p<0.001) and longer procedure time (p=0.014) in the cAVG group. A significant difference in lower reinfection rate (p=0.009) was found in the TGE group. Multivariable analysis confirmed that aAVG significantly independently affected the reinfection rate (hazard ratio, 2.208; 95% confidence interval, 1.069-4.561; p=0.032). Staphylococcus aureus was the most frequent cause of AVG infection (61.5%); 77.5% of Staphylococcus aureus were methicillin-resistant Staphylococcus aureus. Conclusion: We found a higher risk of reinfection after PGE than TGE, and aAVG infection was associated with approximately two times higher likelihood of reinfection. These findings suggest that TGE should be considered for patients with AVG infections, particularly aAVG infections.

3.
Gen Thorac Cardiovasc Surg ; 68(12): 1479-1482, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32008186

ABSTRACT

A 72-year-old man presented with recurrent constrictive pericarditis, which developed 6 months after pericardiectomy, and pericardial substitution with an expanded polytetrafluoroethylene membrane. Re-pericardiectomy was performed. A new thick membranous structure had grown under the expanded polytetrafluoroethylene membrane anterior to the right ventricle, and was firmly adhered to the epicardium. This new structure exhibited collagenous fiber-based fibrotic thickening, and resembled a foreign body reaction. It was surmised that recurrence of constrictive pericarditis may have been induced by the expanded polytetrafluoroethylene membrane. Heart failure resolved after the operation; however, the patient died of respiratory failure on postoperative day 6.


Subject(s)
Heart Failure , Pericarditis, Constrictive , Aged , Humans , Male , Pericardiectomy , Pericarditis, Constrictive/diagnostic imaging , Pericarditis, Constrictive/etiology , Pericardium , Polytetrafluoroethylene
4.
Gen Thorac Cardiovasc Surg ; 64(1): 34-7, 2016 Jan.
Article in English | MEDLINE | ID: mdl-24317742

ABSTRACT

Cardiac hemangiomas are extremely rare tumors, accounting for only 2.5% of all cardiac tumors. Most of these develop in the ventricles, and obtaining a good field of view is, therefore, the key to successful operation. A 40-year-old female visited a local hospital due to palpitation. Transthoracic echocardiography revealed a spherical high-echo mass (13.5 × 10.7 mm in diameter) between the papillary muscles. She was referred to our hospital to undergo close examination. Cardiac contrast-enhanced magnetic resonance imaging was performed to differentiate between malignant and benign lesions. However, this did not provide any findings leading to a definite diagnosis. To make a diagnosis and prevent embolism, the mass was excised using a right minithoracotomy approach with thoracoscopic assistance. The post-operative pathological diagnosis was a cardiac capillary-cavernous hemangioma. A right minithoracotomy approach combined with thoracoscopy allowed accurate evaluation of the mass in the left ventricle beyond the mitral valve and its accurate excision.


Subject(s)
Heart Neoplasms/surgery , Hemangioma/surgery , Thoracoscopy/methods , Thoracotomy/methods , Adult , Female , Heart Neoplasms/diagnostic imaging , Hemangioma/diagnostic imaging , Humans , Minimally Invasive Surgical Procedures/methods , Ultrasonography
5.
Kyobu Geka ; 68(2): 113-6, 2015 Feb.
Article in Japanese | MEDLINE | ID: mdl-25743353

ABSTRACT

A 51-year-old woman was stabbed in the chest with a kitchen knife. Twenty minutes after arrival at our hospital by ambulance, she was transferred to the operating room, and a cardiopulmonary bypass was established from the right femoral artery and vein, and a median sternotomy was performed. The knife had damaged the surface of the heart and penetrated the lingular segment of the left lung. Both wounds were directly sutured. Chest X-rays taken after closing the chest showed bleeding in the left lung probably because of the administration of heparin. Bleeding was controlled by lingulectomy. The postoperative course was uneventful.


Subject(s)
Heart Injuries/surgery , Lung Injury/surgery , Lung/surgery , Female , Humans , Middle Aged , Suicide, Attempted , Tomography, X-Ray Computed
6.
Asian Cardiovasc Thorac Ann ; 22(3): 329-31, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24585910

ABSTRACT

A 57-year-old man presented with acute right ventricular infarction. A percutaneous coronary intervention was undertaken, but he developed shock and required extracorporeal membrane oxygenator support. Coronary artery bypass was performed, and a Abiomed BVS 5000 was implanted as a right ventricular assist device. Circulation gradually stabilized, and the device was removed after 5 days. There no sign of heart failure or infection at 9 months post-surgery.


Subject(s)
Coronary Artery Bypass , Extracorporeal Membrane Oxygenation , Heart-Assist Devices , Myocardial Infarction/therapy , Shock, Cardiogenic/therapy , Combined Modality Therapy , Humans , Male , Middle Aged , Myocardial Infarction/complications , Myocardial Infarction/diagnosis , Myocardial Infarction/physiopathology , Percutaneous Coronary Intervention , Prosthesis Design , Shock, Cardiogenic/diagnosis , Shock, Cardiogenic/etiology , Shock, Cardiogenic/physiopathology , Time Factors , Treatment Outcome , Ventricular Function, Right
7.
Asian J Surg ; 37(1): 46-8, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23978424

ABSTRACT

Infection of a vascular prosthesis after a bypass surgery is relatively rare. However, once developed, serious complications can occur, such as bleeding, sepsis, and organ ischemia, occasionally resulting in leg amputation or even death in some cases. The treatment of a vascular prosthesis infection involves the necessary removal of the infected graft; subsequently, an extra-anatomical bypass surgery is often considered. We herein report a case in which postoperative methicillin-resistant Staphylococcus aureus infection caused dehiscence of the femoral vessels and exposure of the graft vessel and anastomosed area. The infected tissue was surgically removed (debridement), and the patient's condition was successfully treated by the application of a nonadherent dressing and vacuum-assisted closure therapy combined with the bridging technique.


Subject(s)
Blood Vessel Prosthesis Implantation , Methicillin-Resistant Staphylococcus aureus , Negative-Pressure Wound Therapy , Postoperative Complications , Staphylococcal Infections/therapy , Humans , Male , Middle Aged , Popliteal Artery/surgery , Salvage Therapy/methods
8.
Gen Thorac Cardiovasc Surg ; 60(12): 796-802, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23054613

ABSTRACT

OBJECTIVE: Constrictive pericarditis is a disease characterized by marked thickening of the pericardium which causes restriction of diastolic cardiac function. The purpose of this report is to review the outcome of pericardiectomy for constrictive pericarditis and to discuss its problems. METHODS: Sixteen consecutive patients who underwent pericardiectomy for constrictive pericarditis in our institution between March 2000 and June 2011 were reviewed. All patients underwent decortication including at least the anterior surface from the right atrium to the left phrenic nerve and the diaphragmatic surface of the heart. The epicardium was concomitantly resectioned because it was usually sclerotic and constrictive. RESULTS: Postoperatively, mean central venous pressure decreased to 8.8 ± 3.1 mmHg and was significantly lower than the preoperative value 15.3 ± 3.7 mmHg (p < 0.001). The mean postoperative duration of hospitalization was 25.6 ± 13.5 days. There were 2 in-hospital deaths and early mortality rate was 12.5 %; however, excluding hospital deaths, there were no significant postoperative complications and all survivors recovered and maintained good cardiac function during the mean follow-up period of 3.7 ± 2.8 years. CONCLUSION: For an acceptable outcome, surgical intervention should be performed at an appropriate time and the pericardiectomy should have proper scope and depth to prevent irreversible changes in the heart, liver, and other organs.


Subject(s)
Pericardiectomy , Pericarditis, Constrictive/surgery , Adult , Aged , Chronic Disease , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pericardiectomy/adverse effects , Pericardiectomy/methods , Pericardium/physiopathology , Pericardium/surgery
9.
Gen Thorac Cardiovasc Surg ; 60(9): 561-8, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22767297

ABSTRACT

OBJECTIVE: The ATS Open Pivot mechanical heart valve has been implanted routinely at our institution since 1999. The objective of this study is to retrospectively analyze our 12-year clinical results with ATS prostheses. METHODS: ATS Open Pivot mechanical valves were implanted in 268 adult patients between May 1999 and August 2010. We selected 259 subjects who could be adequately followed (follow-up rate 96.6 %). Aortic valve replacement was performed in 157 patients, mitral valve replacement (MVR) in 71, and double (aortic and mitral) valve replacements (DVR) in 31. Mean age at the time of implant was 58.8 ± 10.6 years. The gender ratio was 128 males/131 females. Mean follow-up was 4.4 ± 7.8 years, and the cumulative follow-up was 1144 patient-years (pt-yr). RESULTS: Early death within 30 days after the operation occurred in 5 (2.5 %) patients. Late death occurred in 27 patients including valve-related deaths in 13. The 10-year survival rate after the operation was 82.7 ± 2.9 %. The rate of freedom from valve-related death was 92.2 ± 2.2 %. The incidence of valve-related complications was 2.19 %/pt-yr. Of these, the incidence of thromboembolic events and that of bleeding complications were 1.22 and that 0.87 %/pt-yr. The incidence of valve thrombosis was 0.09 %/pt-yr. No structural valve deterioration was observed in any of the three operative procedure groups. CONCLUSIONS: Our 12-year experience with aortic and MVR using the ATS mechanical heart valve demonstrated low incidences of thromboembolic events, bleeding complications, and valve thrombosis.


Subject(s)
Aortic Valve/surgery , Heart Valve Diseases/therapy , Heart Valve Prosthesis Implantation/instrumentation , Heart Valve Prosthesis , Mitral Valve/surgery , Aged , Anticoagulants/therapeutic use , Disease-Free Survival , Female , Heart Valve Diseases/mortality , Heart Valve Prosthesis Implantation/adverse effects , Heart Valve Prosthesis Implantation/mortality , Hospital Mortality , Humans , Incidence , Japan/epidemiology , Kaplan-Meier Estimate , Linear Models , Male , Middle Aged , Postoperative Hemorrhage/epidemiology , Prosthesis Design , Retrospective Studies , Risk Assessment , Risk Factors , Thromboembolism/epidemiology , Time Factors , Treatment Outcome
10.
Gen Thorac Cardiovasc Surg ; 60(8): 507-10, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22610158

ABSTRACT

Some reports suggest that mitral valve repair has good outcomes and may, therefore, be the preferred surgical approach in patients with active infective endocarditis (Doukas et al. in Heart 92(3):361-363, 2006); Ruttmann et al. in J Thorac Cardiovasc Surg 130(3):765-771, 2005; Sternik et al. in J Heart Valve Dis 11(1):91-97, 2002). However, in cases of active infective endocarditis of the mitral valve, extensive destruction of valvular tissue may make reliable valve repair difficult. Moreover, the timing of valve repair for active infective endocarditis remains controversial, especially in patients having cerebral complications. We present a case of a 34-year-old woman who had active infective endocarditis of the mitral valve complicated by multiple acute cerebral infarctions from septic embolisation. We could successfully carry out mitral valve repair 36 h after the diagnosis of active infective endocarditis and cerebral infarction was made. Her postoperative course was uneventful, and the patient remained in good health without recurrence of infective endocarditis and neurological complications.


Subject(s)
Cerebral Infarction/microbiology , Endocarditis, Bacterial/drug therapy , Heart Valve Prosthesis Implantation , Mitral Valve Annuloplasty , Mitral Valve/surgery , Streptococcal Infections/drug therapy , Adult , Anti-Bacterial Agents/therapeutic use , Cerebral Infarction/diagnosis , Echocardiography, Doppler , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/microbiology , Female , Heart Valve Prosthesis Implantation/instrumentation , Humans , Magnetic Resonance Imaging , Mitral Valve/microbiology , Mitral Valve Annuloplasty/instrumentation , Streptococcal Infections/complications , Streptococcal Infections/diagnosis , Streptococcal Infections/microbiology , Streptococcus/isolation & purification , Time Factors , Treatment Outcome
11.
Gen Thorac Cardiovasc Surg ; 59(11): 737-42, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22083691

ABSTRACT

PURPOSE: The aim of this study was to determine the mechanism of systolic anterior motion (SAM) after mitral valve (MV) repair by analyzing the clinical data of patients with MV repair. METHODS: A total of 104 MV repairs were performed for patients with isolated degenerative posterior leaflet prolapse. Eight patients (7.7%) developed SAM with severe mitral regurgitation. We compared the preoperative and intraoperative findings of the two groups (8 patients in the SAM group, 96 in the non-SAM group) and reported the clinical courses of the SAM patients. RESULTS: Preoperative left ventricular end-diastolic and end-systolic diameters were significantly smaller and the preoperative left ventricular ejection fraction was significantly greater in the SAM group than in the non-SAM group. The number of patients with a sigmoid septum and the number with anterior leaflet-septal contact (LSC) during diastole were significantly larger in the SAM group. Incidence of billowing posterior leaflet, prolapsed segments, and operative techniques were comparable for the two groups. SAM improved with correction of hemodynamic status in four patients. In four other patients secondary cardiopulmonary bypass was required to resolve SAM. SAM resolved with additional repairs in two patients, whereas the other two required MV replacement. Of the six patients in whom conservative treatment or re-repair was successful, one had recurrent SAM 3 months after surgery. CONCLUSION: The sigmoid septum and LSC may predict SAM after MV repair. A strict follow-up is imperative for patients with persistent or recurrent SAM.


Subject(s)
Heart Valve Diseases/etiology , Heart Valve Prosthesis Implantation/adverse effects , Mitral Valve Annuloplasty/adverse effects , Mitral Valve Prolapse/surgery , Mitral Valve/surgery , Aged , Chi-Square Distribution , Female , Heart Valve Diseases/diagnostic imaging , Heart Valve Diseases/physiopathology , Heart Valve Diseases/surgery , Hemodynamics , Humans , Japan , Male , Middle Aged , Mitral Valve/diagnostic imaging , Mitral Valve/physiopathology , Mitral Valve Prolapse/diagnostic imaging , Mitral Valve Prolapse/physiopathology , Recurrence , Reoperation , Retrospective Studies , Risk Assessment , Risk Factors , Stroke Volume , Systole , Time Factors , Treatment Outcome , Ultrasonography , Ventricular Function, Left
12.
Ann Thorac Surg ; 92(4): 1508-10, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21958805

ABSTRACT

A floating thrombus in the ascending aorta is an uncommon source of embolism. We report a case in which a floating mass in the left coronary sinus of Valsalva caused intermittent left main coronary trunk occlusion, leading to myocardial ischemia and cardiogenic shock. The mass was surgically resected. Macroscopically, the aortic wall and leaflets were normal. On histologic examination the mass was found to be a thrombus. This patient had a low level of protein C; therefore, it was presumed that the thrombus was due to protein C deficiency.


Subject(s)
Aorta, Thoracic/diagnostic imaging , Coronary Stenosis/etiology , Coronary Thrombosis/complications , Protein C Deficiency/complications , Protein C/metabolism , Sinus of Valsalva , Thrombectomy/methods , Adult , Coronary Angiography , Coronary Stenosis/diagnosis , Coronary Stenosis/surgery , Coronary Thrombosis/diagnosis , Coronary Thrombosis/surgery , Diagnosis, Differential , Echocardiography, Transesophageal , Female , Follow-Up Studies , Humans , Protein C Deficiency/blood , Tomography, X-Ray Computed
13.
Ann Vasc Dis ; 4(1): 32-6, 2011.
Article in English | MEDLINE | ID: mdl-23555424

ABSTRACT

OBJECTIVE: A modified Bentall procedure with a Carrel patch and inclusion technique (Modified Bentall Procedure) has been used to treat combined disease of the aortic valve and aortic root. The current study examined the outcomes of this surgical technique. MATERIALS AND METHODS: Between April 1999 and March 2009, 16 patients (10 males, 6 females; 63.3 ± 9.4 years) underwent elective surgery involving the Modified Bentall Procedure and no additional surgery, so they were included in the study. RESULTS: The mean cardiopulmonary bypass time was 140.2 ± 34.4 min (range: 97-232 min), and aortic cross-clamp time was 97.3 ± 16.6 min (range: 76-132 min). There were no hospital deaths. No patients required additional surgery to correct excessive bleeding. The follow-up rate was 100% (16/16). The mean follow-up period was 5.6 ± 2.8 years (range: 0.7-9.9 years). One of the 16 patients died (6.3%) due to lung cancer, and 1 of the 15 surviving patients required additional surgery (6.7%) for a thoracic aortic aneurysm. Kaplan-Meier analysis found that 1-year and 5-year survival and event-free survival rates were all 100%. CONCLUSIONS: The Modified Bentall Procedure provided satisfactory results over both the short term and long term.

14.
Ann Thorac Cardiovasc Surg ; 16(1): 26-30, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20190706

ABSTRACT

BACKGROUND: The purpose of this study was to determine the long-term results of a 7-year follow-up of endovascular aneurysm repairs (EVARs) of abdominal aortic aneurysms (AAAs) using custom-made stent grafts (SGs). METHODS AND RESULTS: We performed a retrospective review of 17 patients (14 males, 3 females; mean age: 74.3 +/- 7.9 years; range: 53-85) undergoing EVAR of infrarenal aortic aneurysms at our institution from April 2000 to August 2006. The primary and secondary clinical success rates were 82.4% (14/17) and 100% (17/17). The initial and short-term clinical success rates were 100%. During follow-up (mean: 38.8 +/- 35.9 months; range: 0.8-90 months), 4 patients died, but there was no aneurysm-related death. In 2 patients, additional surgery was performed. The long-term clinical success rate was 83.3% (5/6). In the Kaplan-Meier curve, the 1- and 5-year survival rates were 55.0% and 45.8%, respectively. CONCLUSION: The initial and short-term clinical success rates were 100%; regarding the short-term, aneurysm-related death could be avoided. However, during long-term follow-up, aneurysm-related events did occur. Follow-up should be performed over a long period.


Subject(s)
Aortic Aneurysm, Abdominal/surgery , Blood Vessel Prosthesis Implantation/instrumentation , Blood Vessel Prosthesis , Stents , Aged , Aged, 80 and over , Aortic Aneurysm, Abdominal/mortality , Blood Vessel Prosthesis Implantation/adverse effects , Blood Vessel Prosthesis Implantation/mortality , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Prosthesis Design , Retrospective Studies , Time Factors , Treatment Outcome
15.
Gen Thorac Cardiovasc Surg ; 57(1): 10-21, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19160006

ABSTRACT

PURPOSE: Residual mitral regurgitation (MR) is a risk factor of reoperation. Here we report the midterm results of mitral valve repair for degenerative disease with mitral valve prolapse and identify important factors for durable repair. METHODS: From April 1999 to September 2007, 116 patients with leaflet prolapse (59 men; mean age 63 years) underwent mitral valve repair; they consisted of 19 anterior, 67 posterior, 23 bileaflet, and 7 isolated commissures. The mean clinical and echocardiographic follow-ups were at 4.1 +/- 2.3 and 3.3 +/- 2.4 years, respectively. RESULTS: Altogether, 12 patients showed recurrent moderate or severe MR during the follow-up period; and 10 of the 12 patients (83.8%) had recurrent moderate or severe MR within 1.5 years. Causes of early MR recurrence were dehiscence of sutured segments and ineffectiveness of the artificial chords. The rates of freedom from reoperation at 3 and 7 years were 95.3% +/- 2.0% and 91.0% +/- 4.7%, respectively. The rates of freedom from recurrent moderate or severe MR at 3 and 7 years were 90.5% +/- 2.9% and 83.8% +/- 5.9%, respectively. CONCLUSIONS: The prevention of dehiscence of the sutured segment and reestablishment of coaptation using artificial chords are imperative to maintain the durability of mitral valve repair for patients with degenerative disease.


Subject(s)
Heart Valve Prosthesis Implantation/instrumentation , Heart Valve Prosthesis , Mitral Valve Insufficiency/surgery , Mitral Valve Prolapse/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Atrial Fibrillation/etiology , Endocarditis/etiology , Female , Heart Valve Prosthesis Implantation/adverse effects , Heart Valve Prosthesis Implantation/mortality , Humans , Male , Middle Aged , Mitral Valve Insufficiency/etiology , Mitral Valve Insufficiency/mortality , Mitral Valve Prolapse/complications , Mitral Valve Prolapse/mortality , Postoperative Hemorrhage/etiology , Prosthesis Design , Prosthesis Failure , Recurrence , Reoperation , Retrospective Studies , Suture Techniques , Thromboembolism/etiology , Time Factors , Treatment Outcome , Young Adult
16.
Clin Drug Investig ; 26(4): 215-22, 2006.
Article in English | MEDLINE | ID: mdl-17163254

ABSTRACT

BACKGROUND: Bisphosphonate drugs, including etidronic acid, are effective agents for the treatment of osteoporosis and may reduce arterial calcification. The aim of this randomised control trial was to characterise the effect of etidronic acid on arterial calcification in patients undergoing chronic haemodialysis. METHODS: Patients undergoing chronic haemodialysis were assigned to one of two groups by a simple randomisation method: an etidronic acid group (n = 8; 400 mg/day for 24 weeks) and a control group (n = 6; no etidronic acid therapy). Serum calcium, phosphate, calcium-phosphate product, alkaline phosphatase, lactate dehydrogenase, activated colecalciferol and parathyroid hormone levels were measured at baseline and then at 4-weekly intervals thereafter. RESULTS: Calcification scores of the coronary arteries and the thoracic and abdominal aorta were determined by volume-correcting data collected by a multi- detector-row computerised tomographic scanner at baseline, at 6 months and at 1 year. Two patients in the etidronic acid group were excluded from the final analysis because of medical complications. The remainder of the patients (n = 6) showed no significant temporal changes in serum levels of assessed parameters. While no significant temporal changes in coronary calcification score were observed in either group, the mean aortic calcification score significantly decreased over time from 1000 +/- 460mm(3 )at baseline to 970 +/- 580mm(3) at the completion of treatment and 350 +/- 180mm(3) at 1 year (p = 0.009), corresponding to a mean percentage decrease of -64.1% (range -86.5% to -50.1%). By contrast, in the control group, the mean aortic calcification score significantly increased with time from 1460 +/- 1280mm(3) to 1510 +/- 1150mm(3) at the completion of treatment and 2070 +/- 1200mm(3) at 1 year (p = 0.006), corresponding to a mean percentage change in the calcification score of +130.0% (range 2.1-414%). CONCLUSION: Etidronic acid markedly reduced aortic calcification in patients with end-stage renal disease undergoing chronic haemodialysis. The effect of this agent on aortic calcification may attenuate the increase in aortic stiffness and result in improved long-term outcomes in patients undergoing chronic haemodialysis.


Subject(s)
Calcinosis/prevention & control , Etidronic Acid/therapeutic use , Renal Dialysis/methods , Aged , Aorta, Abdominal/drug effects , Aorta, Abdominal/metabolism , Aorta, Abdominal/pathology , Aorta, Thoracic/drug effects , Aorta, Thoracic/pathology , Bone Density Conservation Agents/administration & dosage , Bone Density Conservation Agents/adverse effects , Bone Density Conservation Agents/therapeutic use , Calcinosis/chemically induced , Coronary Vessels/drug effects , Coronary Vessels/metabolism , Coronary Vessels/pathology , Drug Administration Schedule , Etidronic Acid/administration & dosage , Etidronic Acid/adverse effects , Female , Humans , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/therapy , Male , Middle Aged , Myocardial Ischemia/complications , Myocardial Ischemia/drug therapy , Pilot Projects , Time Factors , Tomography, X-Ray Computed , Treatment Outcome
17.
Ann Thorac Cardiovasc Surg ; 12(4): 257-64, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16977295

ABSTRACT

PURPOSE: The goal of this study was to evaluate perioperative and mid-term results of coronary artery bypass grafting (CABG) in patients with end-stage renal disease (ESRD). METHODS: Thirty-five consecutive dialysis patients who required CABG over a 5-year period were investigated retrospectively. RESULTS: Mean patient age was 62.5+/-11.5 years. The mean number of diseased vessels was 2.3W0.8. Off-pump CABG (OPCAB) was performed in 12 patients. The mean number of anastomoses per patient was 2.5+/-1.1. The perioperative mortality was 5.7%, and the average duration of hospitalization was 25.3+/-13.4 days. Overall 5-year survival rates were 63.7%. The cardiac-related 5-year survival rate was 89.3%, and the cardiac event-free rate was 51.7%. Multivariate analysis failed to identify any significant prognosticators for perioperative or long-term outcomes. The morbidity rate was significantly lower in patients undergoing OPCAB than in patients undergoing conventional CABG (8.3 vs. 47.8%; p=0.03). Perioperative mortality in the OPCAB group was 0%, and the average duration of hospitalization was shorter in the OPCAB group than in the conventional CABG group (19.7 days vs. 28.5 days; p=0.1). CONCLUSION: In the context of coronary artery bypass surgery, OPCAB produced better outcomes than conventional CABG procedure in patients undergoing chronic dialysis. Further-more, OPCAB procedure seems to offer a greater benefit to dialysis patients than non-dialysis patients.


Subject(s)
Coronary Artery Bypass, Off-Pump , Coronary Artery Bypass , Kidney Failure, Chronic/therapy , Renal Dialysis , Adult , Aged , Aged, 80 and over , Coronary Artery Bypass/adverse effects , Coronary Artery Bypass, Off-Pump/adverse effects , Female , Follow-Up Studies , Humans , Kidney Failure, Chronic/mortality , Length of Stay , Male , Middle Aged , Preoperative Care , Retrospective Studies , Survival Analysis , Time Factors , Treatment Outcome
18.
Ann Thorac Surg ; 80(6): 2364-5, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16305914

ABSTRACT

A 54-year-old male who experienced a syncopal episode underwent aortic valve replacement for aortic stenosis and regurgitation. The aortic valve was incompetent as a result of thickening of the left coronary cusp and noncoronary cusp. In addition a saccular aneurysm was indicated on the left coronary cusp. A shelf of tissue protruding at right angles from the ventricular septum was particularly prominent below the right coronary cusp, resulting in subvalvular stenosis. The cause of the saccular aneurysm was most likely caused by the long-term effects of the jet stream instigated by discrete subaortic stenosis.


Subject(s)
Aortic Aneurysm, Thoracic/complications , Discrete Subaortic Stenosis/complications , Humans , Male , Middle Aged
19.
Ann Thorac Cardiovasc Surg ; 10(5): 307-10, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15563269

ABSTRACT

Cardiac transplantation is an established treatment for end-stage heart failure, but its use is very limited. Partial left ventriculectomy has been reported as an alternative treatment for end-stage dilated cardiomyopathy. However, it has been well recognized that emergency partial left ventriculectomy for intractable decompensation is associated with poor survival. We report a case of a 68-year-old man with a left ventricular end-diastolic diameter of 108 mm, who underwent emergency extended partial left ventriculectomy, without papillary muscle resection, and mitral valve replacement with chordae preservation to deal with ongoing cardiogenic shock caused by end-stage dilated cardiomyopathy. The patient's cardiac status and general condition improved after the operation, and he survived the crisis. This operation should be considered as an alternative strategy for patients with septal motion and very large left ventricle. Thus, we report a successful extended partial left ventriculectomy and mitral valve replacement for end-stage dilated cardiomyopathy with very large left ventricular end-diastolic diameter.


Subject(s)
Cardiomyopathy, Dilated/complications , Hypertrophy, Left Ventricular/etiology , Hypertrophy, Left Ventricular/surgery , Palliative Care/methods , Aged , Cardiomyopathy, Dilated/mortality , Echocardiography , Emergencies , Humans , Hypertrophy, Left Ventricular/diagnosis , Hypertrophy, Left Ventricular/physiopathology , Intra-Aortic Balloon Pumping , Male , Mitral Valve Insufficiency/diagnosis , Mitral Valve Insufficiency/etiology , Mitral Valve Insufficiency/surgery , Myocardial Contraction , Oxygen Consumption , Papillary Muscles/surgery , Patient Selection , Severity of Illness Index , Shock, Cardiogenic/etiology , Stroke Volume , Survival Rate , Treatment Outcome
20.
Ann Thorac Cardiovasc Surg ; 10(2): 90-6, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15209550

ABSTRACT

OBJECTIVE: Off-pump coronary artery bypass grafting (OPCAB) may reduce the inflammatory response associated with cardiopulmonary bypass (CPB) and contribute to minimizing postoperative complications. Heparin-coated circuits and poly2methoxyethylacrylate (PMEA)-coated circuits were developed to reduce such complications. We compared the postoperative inflammatory response with or without CPB. METHODS: Eighteen consecutive patients undergoing isolated coronary artery bypass grafting (CABG) were divided into three groups: OPCAB group (n=6), heparin-coated circuits group (n=6), PMEA-coated circuits group (n=6). The plasma concentrations of the following inflammatory markers were measured: cytokines [interleukin (IL-10)], polymorphonuclear elastase (PMNE), coagulofibrinolytic factor [thrombin-antithrombin III complex (TAT)], complement factor (C3a). RESULTS: At the end of CPB, IL-10 and TAT concentrations were significantly different among the three groups (OPCAB group < PMEA-coated group < heparin-coated group). The PMNE concentration was significantly lower in the OPCAB group and the heparin-coated group as compared to the PMEA-coated group both at the end of CPB and 4 hours after CPB. C3a concentration was significantly lower in the OPCAB group than in the CPB groups at the end of CPB. Clinical variables did not differ significantly among the three groups. CONCLUSION: Off-pump CABG is associated with a reduction in the inflammatory response when compared with on-pump CABG, using either PMEA-coated or heparin-coated circuits.


Subject(s)
Cardiopulmonary Bypass/adverse effects , Cardiopulmonary Bypass/instrumentation , Coronary Artery Bypass/adverse effects , Coronary Artery Bypass/instrumentation , Inflammation/immunology , Acrylates/pharmacology , Aged , Aged, 80 and over , Anticoagulants/pharmacology , Biocompatible Materials/pharmacology , Biomarkers , Female , Heparin/pharmacology , Humans , Immune System/drug effects , Male , Middle Aged , Polymers/pharmacology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...